Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares Repurchased
Ratios

Core Laboratories (CLB) Accumulated Depreciation & Amortization (2022 - 2025)

Core Laboratories filings provide 4 years of Accumulated Depreciation & Amortization readings, the most recent being $320.7 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 2.03% to $320.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $320.7 million, a 2.03% increase, with the full-year FY2025 number at $320.7 million, up 2.03% from a year prior.
  • Accumulated Depreciation & Amortization hit $320.7 million in Q4 2025 for Core Laboratories, up from $314.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $320.7 million in Q4 2025 to a low of $314.3 million in Q4 2024.
  • Median Accumulated Depreciation & Amortization over the past 4 years was $315.3 million (2022), compared with a mean of $316.4 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: fell 0.47% in 2024 and later grew 2.03% in 2025.
  • Core Laboratories' Accumulated Depreciation & Amortization stood at $314.7 million in 2022, then increased by 0.34% to $315.8 million in 2023, then fell by 0.47% to $314.3 million in 2024, then rose by 2.03% to $320.7 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $320.7 million (Q4 2025), $314.3 million (Q4 2024), and $315.8 million (Q4 2023) per Business Quant data.